Reference list 1. Bechman, K., Song, K., Abhishek Abhishek, Adas, M., Ahmed, A., Bray, L., Davidson, A., Samundeeswari Deepak, Dey, M., Vere, H. D., Dhillon, E., Faithfull, N., Foulkes, A., Gibson, M., Gullick, N., Hartley, K., Heaton, R., Hider, S., Holmes, J., & Jones, C. (2025). The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease - modifying anti - rheumatic drugs. Lara D. Veeken , 65 (2). https://doi.org/10.1093/rheumatology/keaf522 2. Cooper, M., Trotter, V., Hand, A., & Nazar, H. (2025). Specialist medication monitoring and prescribing in primary care: case study of shared care agreements in Northern England, UK. BMJ Open Quality , 14 (4), e003491. https://doi.org/10.1136/bmjoq - 2025 - 003491 3. Ministry of Housing, Communities and Local Government. (2025). English indices of deprivation 2025 . GOV.UK. https://www.gov.uk/government/statistics/english - indices - of - deprivation - 2025 4. North East and North Cumbria Integrated Care Board. (2025 , December 11 ). NENC shared care protocol: Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care). https://ntag.nhs.uk/wp - content/uploads/2026/03/NENC - SCP - methotrexate - in - adults - excluding - cancer - care - v1.0 - approved - Dec - 2025 - review - date - extended.docx